IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
Future Market Insights4 小时
Global Submucosal Lifting Agent Market Set for Robust Growth, Projected to Reach USD 222.6 ...
The global submucosal lifting agent market is on a trajectory for remarkable growth, with projections indicating a compound ...
Cosmetic Laser Market Size, Share And Forecast To 2033
Introduction Cosmetic lasers are a therapy used to treat face wrinkles and imperfections such as skin laxity, moles, liver spots, excess fat, a ...
PharmiWeb4 小时
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with ...
Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
Global Mechanical Debridement Market Size, Growth, Industry Trends Emergen Research
Segment Insights The hydrotherapy devices segment dominates the market due to its widespread use in hospitals and specialized wound care clinics. Hydrotherapy devices are effective in cleaning wounds ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...